Pipeline - PeakLogic Development Pipeline

DEVELOPMENT PIPELINE

PrTMS^® has not been evaluated in clinical research studies to date. However, PeakLogic^® plans to pursue studies evaluating use of the PrTMS^® protocol for the treatment of major mental health and neurocognitive disorders, including human performance. PeakLogic^® also hopes to pursue FDA-clearance of new products that may improve TMS therapy more broadly.

PeakLogic^® plans to research the potential safety and efficacy of PrTMS^® for a variety of conditions, including:

Addiction

Anxiety

Autism

Cerebral Palsy

Depression

Human Performance

Memory Loss

PTSD

Sleep Disorders

Other Neurocognitive Conditions

My partnership with Dr. Murphy and PeakLogic^® has been one of the best business decisions I’ve ever made. He and his team have risen far above my expectations in terms of tech support, teaching, training, and patient care logistics.

TERESA M. ANDERSON, M.D.,
THE ANDERSON CLINIC